MedTrace Logo

Bupropion for Smoking Cessation in Pregnancy

NCT01875172 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2013-06-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether bupropion SR increases cessation and/or smoking reduction among pregnant smokers.

Conditions

  • Smoking Cessation
  • Pregnancy

Interventions

DRUG

Bupropion SR

Comparison of bupropion SR or placebo + smoking cessation counseling

DRUG

placebo

BEHAVIORAL

smoking cessation counseling

Sponsors & Collaborators

  • University of Arizona

    collaborator OTHER

  • Watching Over Mothers & Babies Foundation

    lead OTHER

Principal Investigators

  • Hugh S Miller, MD · Watching Over Mothers and Babies Foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2004-01-31
Completion
2004-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01875172 on ClinicalTrials.gov